REPHRESH VAGINAL GEL

K021737 · Columbia Laboratories, Inc. · NUC · Aug 26, 2002 · Obstetrics/Gynecology

Device Facts

• Record ID: K021737
• Device Name: REPHRESH VAGINAL GEL
• Applicant: Columbia Laboratories, Inc.
• Product Code: NUC · Obstetrics/Gynecology
• Decision Date: Aug 26, 2002
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 884.5300
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

May be used as a personal lubricant when vaginal dryness causes discomfort. Also eases insertion of tampons.

Device Story

RepHresh Vaginal Gel is a personal lubricant intended for use when vaginal dryness causes discomfort or to ease tampon insertion. The device is applied topically to the vaginal area. It functions as a lubricant to reduce friction and alleviate discomfort associated with dryness. It is intended for over-the-counter use by patients.

Clinical Evidence

No clinical data provided; bench testing only.

Indications for Use

Indicated for individuals experiencing vaginal dryness causing discomfort and to facilitate the insertion of tampons.

Regulatory Classification

Identification

A condom is a sheath which completely covers the penis with a closely fitting membrane. The condom is used for contraceptive and for prophylactic purposes (preventing transmission of sexually transmitted infections). The device may also be used to collect semen to aid in the diagnosis of infertility.

Special Controls

*Classification.* (1) Class II (special controls) for condoms made of materials other than natural rubber latex, including natural membrane (skin) or synthetic.(2) Class II (special controls) for natural rubber latex condoms. The guidance document entitled “Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300” will serve as the special control. See § 884.1(e) for the availability of this guidance document.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle with three lines representing its wings and head. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the eagle image.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

FEB 2 4 2014

Ms. Susan A. Witham Vice President, Regulatory Affairs Columbia Laboratories, Inc. 100 North Village Avenue Suite 32 ROCKVILLE CENTER, NY 11570

Re: K021737 Trade/Device Name: RepHresh Vaginal Gel™ Regulation Number: 21 CFR 8884.5300 Regulation Name: Condom Regulatory Class: II Product Code: NUC Dated (Date on orig SE ltr): May 24, 2002 Received (Date on orig SE Itr): May 28, 2002

Dear Ms. Witham:

This letter corrects our substantially equivalent letter of September 19, 2002.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be

{1}------------------------------------------------

Page 2 -

found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office

of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

## Benjamin R. Fisher -S

Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Page ________ of _____________________________________________________________________________________________________________________________________________________________

510(k) Number: K021737

RepHresh™ Vaginal Gel Personal Lubricant Device Name:

Indications for Use:

May be used as a personal lubricant when vaginal dryness causes discomfort. Also eases insertion of tampons.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED.)

Concurrence of CDRH, Office of Device Evaluation (ODE)

| Prescription Use<br>(Per 21 CFR 801.109) | OR | Over-the-Counter Use<br>(Optional Format 1-2-96) <div style="text-align: right;">✓</div> |
|------------------------------------------|----|------------------------------------------------------------------------------------------|
|------------------------------------------|----|------------------------------------------------------------------------------------------|

| (Division Sign-Off) | <i>Nancy C Brogdon</i> |
|---------------------------------------------------------------|------------------------|
| Division of Reproductive, Abdominal, and Radiological Devices | |
| 510(k) Number | K021737 |